Once weekly administration of which of the following antibiotics has prophylactic activity against bacteremia caused by M. avium complex in AIDS patients?
**Core Concept**
The question tests the student's knowledge of antimicrobial prophylaxis in AIDS patients, specifically focusing on the prevention of bacteremia caused by **Mycobacterium avium** complex (MAC). This is a critical consideration in immunocompromised individuals, such as those with advanced HIV infection.
**Why the Correct Answer is Right**
The correct answer is related to the antibiotic that has been shown to effectively prevent MAC bacteremia when administered once weekly. This involves understanding the pharmacokinetics and antimicrobial spectrum of the drug, including its ability to penetrate into tissues and cells where MAC resides.
**Why Each Wrong Option is Incorrect**
**Option A:** This choice is incorrect because it does not match the known prophylactic regimen for MAC bacteremia.
**Option B:** Similarly, this option does not align with recommended prophylaxis strategies for MAC in AIDS patients.
**Option C:** This choice is also incorrect as it is not recognized for weekly prophylaxis against MAC bacteremia.
**Why Each Wrong Option is Incorrect (Continued)**
**Option D:** Although azithromycin is used for various infections, the question's context points towards another antibiotic for MAC prophylaxis.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that prophylaxis against MAC is crucial in AIDS patients with low CD4 counts, and the chosen antibiotic must have a suitable profile for this purpose.
**Correct Answer:** Correct Answer: D. Azithromycin.